These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26674284)

  • 1. Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
    Kozler P; Sobek O; Pokorný J
    Physiol Res; 2015; 64(Suppl 5):S603-8. PubMed ID: 26674284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical manifestations of the nervous tissue degradation after the blood-brain barrier opening or water intoxication in rats.
    Kozler P; Sobek O; Pokorny J
    Neuro Endocrinol Lett; 2016; 37(2):114-20. PubMed ID: 27179573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of methylprednisolone on the axonal impairment accompanying cellular brain oedema induced by water intoxication in rats.
    Kozler P; Pokorny J
    Neuro Endocrinol Lett; 2012; 33(8):782-6. PubMed ID: 23391979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin damage of hippocampus and cerebral cortex in rat pentylenetetrazol model.
    You Y; Bai H; Wang C; Chen LW; Liu B; Zhang H; Gao GD
    Brain Res; 2011 Mar; 1381():208-16. PubMed ID: 21256118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuron-specific Enolase and myelin basic protein in cerebrospinal fluid of patients with first episode schizophrenia.
    Li S; Wu H; Guo H; Zhao Z
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):228-30. PubMed ID: 16850754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Elimination of NSE and MBP into cerebrospinal fluid and blood in acute experimental autoimmune encephalomyelitis].
    Davydovskaia MV; Lebedev SB; Gurina OI; Chekhonin VP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7 Suppl 2):28-31. PubMed ID: 19894310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders.
    Lamers KJ; van Engelen BG; Gabreëls FJ; Hommes OR; Borm GF; Wevers RA
    Acta Neurol Scand; 1995 Sep; 92(3):247-51. PubMed ID: 7484080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid.
    van Engelen BG; Lamers KJ; Gabreels FJ; Wevers RA; van Geel WJ; Borm GF
    Clin Chem; 1992 Jun; 38(6):813-6. PubMed ID: 1375875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both water intoxication and osmotic BBB disruption increase brain water content in rats.
    Kozler P; Riljak V; Pokorný J
    Physiol Res; 2013; 62(Suppl 1):S75-80. PubMed ID: 24329706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylprednisolone reduces axonal impairment in the experimental model of brain oedema.
    Kozler P; Riljak V; Pokorný J
    Neuro Endocrinol Lett; 2011; 32(6):831-5. PubMed ID: 22286794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
    Brouns R; De Vil B; Cras P; De Surgeloose D; Mariën P; De Deyn PP
    Clin Chem; 2010 Mar; 56(3):451-8. PubMed ID: 19959621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic Upregulation of Cleaved-Caspase-3 Associated with Chronic Myelin Pathology and Microvascular Reorganization in the Thalamus after Traumatic Brain Injury in Rats.
    Glushakov AO; Glushakova OY; Korol TY; Acosta SA; Borlongan CV; Valadka AB; Hayes RL; Glushakov AV
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers in Guillain-Barré syndrome--where do we stand?
    Brettschneider J; Petzold A; Süssmuth S; Tumani H
    J Neurol; 2009 Jan; 256(1):3-12. PubMed ID: 19267167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral markers of brain damage and blood-brain barrier dysfunction.
    Marchi N; Rasmussen P; Kapural M; Fazio V; Kight K; Mayberg MR; Kanner A; Ayumar B; Albensi B; Cavaglia M; Janigro D
    Restor Neurol Neurosci; 2003; 21(3-4):109-21. PubMed ID: 14530574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal fluid markers in neurological disorders.
    Massaro AR; Scivoletto G; Tonali P
    Ital J Neurol Sci; 1990 Dec; 11(6):537-47. PubMed ID: 1707039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of paranodal myelin detachment and sodium channel loss in vivo by Campylobacter jejuni DNA-binding protein from starved cells (C-Dps) in myelinated nerve fibers.
    Piao H; Minohara M; Kawamura N; Li W; Mizunoe Y; Umehara F; Goto Y; Kusunoki S; Matsushita T; Ikenaka K; Maejima T; Nabekura J; Yamasaki R; Kira J
    J Neurol Sci; 2010 Jan; 288(1-2):54-62. PubMed ID: 19880143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal damage is remarkable in patients with acutely worsening symptoms of compression myelopathy: biomarkers in cerebrospinal fluid samples.
    Takahashi H; Aoki Y; Nakajima A; Sonobe M; Terajima F; Saito M; Miyamoto T; Koyama K; Yamamoto K; Furuya T; Koda M; Ohtori S; Yamazaki M; Nakagawa K
    Eur Spine J; 2018 Aug; 27(8):1824-1830. PubMed ID: 29557051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultracytochemical distribution of myelin basic protein after injection into the cerebrospinal fluid. Evidence for transport through the blood-brain barrier and binding to the luminal surface of cerebral veins.
    Vass K; Lassmann H; Wisniewski HM; Iqbal K
    J Neurol Sci; 1984 Mar; 63(3):423-33. PubMed ID: 6202848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myelination changes in the rat optic nerve after prenatal exposure to methamphetamine.
    Melo P; Moreno VZ; Vázquez SP; Pinazo-Durán MD; Tavares MA
    Brain Res; 2006 Aug; 1106(1):21-29. PubMed ID: 16842764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal-fluid Alzheimer's Disease Biomarkers and Blood-Brain Barrier Integrity in a Natural Population of Cognitive Intact Parkinson's Disease Patients.
    Liguori C; Olivola E; Pierantozzi M; Cerroni R; Galati S; Saviozzi V; Mercuri NB; Stefani A
    CNS Neurol Disord Drug Targets; 2017; 16(3):339-345. PubMed ID: 27934563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.